EcoDrugPlus

Glutaminase Kidney Isoform, Mitochondrial

Ensembl ID : ENSMZEG00005014227
Gene Symbol: LOC101482051
2 Cross references
232 Possible Orthologues:

Glutaminase Kidney Isoform, Mitochondrial

Ensembl ID : ENSMZEG00005000355
Gene Symbol: LOC101477408
3 Cross references
230 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSMZEG00005001457
Gene Symbol: GSK3B
3 Cross references
222 Possible Orthologues:

Glycogen Synthase Kinase-3 Alpha

Ensembl ID : ENSMZEG00005018449
Gene Symbol: LOC101487071
3 Cross references
186 Possible Orthologues:

Glycogen Synthase Kinase-3 Beta

Ensembl ID : ENSMZEG00005026006
Gene Symbol: LOC101472422
3 Cross references
187 Possible Orthologues:

Gonadotropin-Releasing Hormone Ii Receptor

Ensembl ID : ENSMZEG00005010048
Gene Symbol: LOC101476979
2 Cross references
155 Possible Orthologues:

Granzyme B

Ensembl ID : ENSMZEG00005010248
Gene Symbol: LOC101464142
2 Cross references
949 Possible Orthologues:

Granzyme B-Like

Ensembl ID : ENSMZEG00005010272
Gene Symbol: LOC101487852
2 Cross references
921 Possible Orthologues:

Granzyme B-Like

Ensembl ID : ENSMZEG00005010259
Gene Symbol: LOC101463843
2 Cross references
950 Possible Orthologues:

Granzyme B-Like

Ensembl ID : ENSMZEG00005004979
Gene Symbol: LOC101480778
2 Cross references
951 Possible Orthologues:

Granzyme E

Ensembl ID : ENSMZEG00005010217
Gene Symbol: LOC101464418
2 Cross references
949 Possible Orthologues:

Growth Hormone Releasing Hormone Receptor

Ensembl ID : ENSMZEG00005007303
Gene Symbol: GHRHR
3 Cross references
191 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).